Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C
- PMID: 20064909
- DOI: 10.1177/0961203309353172
Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C
Abstract
A 57-year-old Japanese woman developed skin eruption, pleuritis, pancytopenia, parotid gland swelling and glomerulonephritis after 7-month treatment with pegylated interferon-alpha and ribavirin for chronic hepatitis C. Disease-specific autoantibodies such as anti-SSA, anti-SSB, anti-Sm and anti-dsDNA antibodies became positive. The diagnosis of systemic lupus erythematosus and Sjögren's syndrome was made and treatment with glucocorticoid pulse followed by oral glucocorticoid was started. It is highly probable that interferon-alpha-induced systemic lupus erythematosus and Sjögren's syndrome in this case. Interferon-alpha might be important pathogenically in these diseases.
Similar articles
-
Interferon alpha and its contribution to autoimmunity.Curr Opin Investig Drugs. 2006 May;7(5):451-6. Curr Opin Investig Drugs. 2006. PMID: 16729722 Review.
-
Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.Arch Dermatol. 1988 Jan;124(1):61-2. Arch Dermatol. 1988. PMID: 3257370 No abstract available.
-
Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.Semin Arthritis Rheum. 2002 Dec;32(3):163-73. doi: 10.1053/sarh.2002.37277. Semin Arthritis Rheum. 2002. PMID: 12528081 Review.
-
Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.Tokai J Exp Clin Med. 1993 Dec;18(3-6):133-8. Tokai J Exp Clin Med. 1993. PMID: 7701526
-
The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.Arch Dermatol. 1988 Jan;124(1):63-71. Arch Dermatol. 1988. PMID: 3257371
Cited by
-
IFN-α induced systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report and literature review.Front Immunol. 2023 Aug 4;14:1223062. doi: 10.3389/fimmu.2023.1223062. eCollection 2023. Front Immunol. 2023. PMID: 37600795 Free PMC article. Review.
-
Primary Sjögren's syndrome with diffuse cystic lung changes developed systemic lupus erythematosus: a case report and literature review.Oncotarget. 2017 May 23;8(21):35473-35479. doi: 10.18632/oncotarget.16010. Oncotarget. 2017. PMID: 28415674 Free PMC article. Review.
-
What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?Arthritis Res Ther. 2011 Feb 28;13(1):205. doi: 10.1186/ar3234. Arthritis Res Ther. 2011. PMID: 21371351 Free PMC article. Review.
-
Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia.J Neuroinflammation. 2023 Mar 30;20(1):88. doi: 10.1186/s12974-023-02718-9. J Neuroinflammation. 2023. PMID: 36997937 Free PMC article.
-
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.Pigment Cell Melanoma Res. 2021 Jul;34(4):683-695. doi: 10.1111/pcmr.12935. Epub 2020 Oct 26. Pigment Cell Melanoma Res. 2021. PMID: 33040466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials